Pharma

Your Article Summary

See Latest Articles

Amylin Pharmaceuticals Announces a New Sales Approach to Better Target the Diabetes Market
Amylin Pharmaceuticals, 05/05/09

Amylin Pharmaceuticals, Inc. announced a new approach to sales within the diabetes market. Amylin's existing primary care and specialty sales forces will merge into a single organization that brings a specialty approach to endocrinologists and diabetes-focused primary care physicians. The changes are expected to be implemented in the next several weeks and will reduce the total number of Amylin sales representatives by approximately 35 percent, or 200 employees, and will result in an annualized benefit of approximately $45 million to GAAP operating results in 2010.

Today in Marketing/Media/ROI...keeping you current

Receive free subspecialty "5-minute updates" via email

Go Go Generics
PharmExec, 12/18/09

MediciNova and Avigen Stockholders Approve Merger
Avigen, 12/18/09

Almirall and Forest Laboratories to Expand Respiratory Collaboration with LAS100977
Forest Laboratories, 12/18/09

 See all of Marketing/Media/ROI